InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,426.00
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.46
(
-0.14%
)
Bitcoin
64,429.36
(
0.25%
)
Post# of 539
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 466
Posts 26939
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 112

Tuesday, 07/10/2012 11:18:16 AM

Tuesday, July 10, 2012 11:18:16 AM

Post# of 539
News BreaksJune 28, 2012 09:22 EDT ACOR
theflyonthewall.com: Acorda Therapeutics shares should be bought on recent weakness, says RBC Capital
After speaking with Acorda's management, RBC Capital predicts that the Street will have growing interest in a Phase III study of the company's stroke treatment. The firm thinks that the treatment could reinforce the company's status as a takeover target and it maintains a $38 target and Outperform rating on the shares.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up